(EPZ-5676 is an aminonucleoside DOT1L histone methyltransferase inhibitor with a KI of 80 PM, which is 37,000 times more inhibitory than other PMTS.)

EPZ-5676 is an aminonucleoside DOT1L histone methyltransferase inhibitor with a KI of 80 PM, which is 37,000 times more inhibitory than other PMTS. Basic information More..
Product Name:EPZ-5676 is an aminonucleoside DOT1L histone methyltransferase inhibitor with a KI of 80 PM, which is 37,000 times more inhibitory than other PMTS.
Synonyms:EPZ-5676 is an aminonucleoside DOT1L histone methyltransferase inhibitor with a KI of 80 PM, which is 37,000 times more inhibitory than other PMTS.
CAS:
MF:
MW:0
EINECS:
Mol File:Mol File
EPZ-5676 is an aminonucleoside DOT1L histone methyltransferase inhibitor with a KI of 80 PM, which is 37,000 times more inhibitory than other PMTS.
Information Error Report
Your Email:
Browse by Nationality EPZ-5676 is an aminonucleoside DOT1L histone methyltransferase inhibitor with a KI of 80 PM, which is 37,000 times more inhibitory than other PMTS. Suppliers China suppliers
EPZ-5676 is an aminonucleoside DOT1L histone methyltransferase inhibitor with a KI of 80 PM, which is 37,000 times more inhibitory than other PMTS. Recommend Suppliers
Recommend You Select Member Companies.
1
Tag: EPZ-5676 is an aminonucleoside DOT1L histone methyltransferase inhibitor with a KI of 80 PM, which is 37,000 times more inhibitory than other PMTS.
  • HomePage | About Us | Member Companies | Advertising | Contact us | Previous WebSite | MSDS | CAS Index | CAS DataBase | Privacy | Terms
  • All products displayed on this website are only for non-medical purposes such as industrial applications or scientific research, and cannot be used for clinical diagnosis or treatment of humans or animals. They are not medicinal or edible.
    According to relevant laws and regulations and the regulations of this website, units or individuals who purchase hazardous materials should obtain valid qualifications and qualification conditions.
  • Copyright © 2023 ChemicalBook All rights reserved.